Company news

Sophia Genetics SA news in 2026

Sophia Genetics SA's news releases, calls and decks from 2026, newest first.

View company

SOPHiA GENETICS Reports Third Quarter 2026 Results

November 3, 2026

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2026 on November 3, 2026

October 20, 2026

SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

October 8, 2026

SOPHiA GENETICS Reports Second Quarter 2026 Results

August 4, 2026

SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies

August 4, 2026

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2026 on August 4, 2026

July 21, 2026

SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting

June 22, 2026

SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares

June 19, 2026

SOPHiA GENETICS Announces Pricing of $50 Million Public Offering of Ordinary Shares

June 16, 2026

SOPHiA GENETICS Announces Proposed Public Offering of Ordinary Shares

June 16, 2026

SOPHiA GENETICS Confirms Leadership Transition Ahead of 2026 Annual General Meeting

June 10, 2026

SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center

June 3, 2026

SOPHiA GENETICS and ARC Regulatory Collaborate to Support EU Clinical Trial Assay Development

June 1, 2026

Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.

May 13, 2026

SOPHiA GENETICS Reports First Quarter 2026 Results

May 5, 2026

SOPHiA GENETICS to Announce Financial Results for First Quarter 2026 on May 5, 2026

April 21, 2026

Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026

April 16, 2026

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results

March 2, 2026

SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference

February 24, 2026

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026

February 17, 2026

SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems

February 10, 2026

SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan

January 12, 2026

SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology

January 7, 2026

Calls in 2026

Decks in 2026